McCarthy, Matthew William

Publications

Sort by

Co-Author Network

selected publications

Optimizing the use of vilobelimab for the treatment of COVID-19. Expert opinion on biological therapy. 2023 Academic Article GET IT
Metformin as a potential treatment for COVID-19. Expert opinion on pharmacotherapy. 2023 Review GET IT
Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19-Reply. JAMA. 2023 Comment GET IT
Interferon lambda as a potential treatment for COVID-19. Expert opinion on biological therapy. 2023 Academic Article GET IT
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial. JAMA. 2023 Academic Article GET IT
Times cited: 5
VV116 as a potential treatment for COVID-19. Expert opinion on pharmacotherapy. 2023 Academic Article GET IT
Times cited: 1
Montelukast as a potential treatment for COVID-19. Expert opinion on pharmacotherapy. 2023 Review GET IT
Anakinra as a potential treatment for COVID-19. Drugs of today (Barcelona, Spain : 1998). 2023 Academic Article GET IT
Times cited: 1
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2023 Academic Article GET IT
Times cited: 11
Effect of Ivermectin 600 μg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial. medRxiv : the preprint server for health sciences. 2022 Article GET IT
Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to Arms. Open forum infectious diseases. 2022 Academic Article GET IT
Times cited: 24
Osteoarticular Mycoses. Clinical microbiology reviews. 2022 Review GET IT
Times cited: 4
Infliximab as a potential treatment for COVID-19. Expert review of anti-infective therapy. 2022 Academic Article GET IT
Ensitrelvir as a potential treatment for COVID-19. Expert opinion on pharmacotherapy. 2022 Academic Article GET IT
Times cited: 2
Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial. medRxiv : the preprint server for health sciences. 2022 Article GET IT
Optimizing the use of Paxlovid in clinical practice. Drugs of today (Barcelona, Spain : 1998). 2022 Academic Article GET IT
Times cited: 2
Treatment of severe COVID-19: an evolving paradigm. Expert opinion on pharmacotherapy. 2022 Academic Article GET IT
Times cited: 4
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2022 Academic Article GET IT
Times cited: 13
Original antigen sin and COVID-19: implications for seasonal vaccination. Expert opinion on biological therapy. 2022 Academic Article GET IT
Times cited: 1
Novel Strategies for the Treatment of COVID-19. Drugs in R&D. 2022 Academic Article GET IT
Times cited: 5
Recent advances in the diagnosis monkeypox: implications for public health. Expert review of molecular diagnostics. 2022 Academic Article GET IT
Times cited: 8
Therapeutic strategies to address monkeypox. Expert review of anti-infective therapy. 2022 Academic Article GET IT
Times cited: 18
Outpatient treatment options to address the SARS-CoV-2 variant Omicron. Expert review of anti-infective therapy. 2022 Academic Article GET IT
Times cited: 4
Fluticasone propionate as a potential treatment for COVID-19. Drugs of today (Barcelona, Spain : 1998). 2022 Academic Article GET IT
Times cited: 2
Exebacase: A Novel Approach to the Treatment of Staphylococcal Infections. Drugs in R&D. 2022 Review GET IT
Times cited: 2
Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19). Expert opinion on pharmacotherapy. 2022 Academic Article GET IT
Times cited: 2
The Association Between Time to First Dose of Venous Thromboembolism Prophylaxis and the Incidence of Hospital-Acquired Venous Thromboembolism. Journal of patient safety. 2022 Academic Article GET IT
The Diagnostic Accuracy Of Procalcitonin for Urinary Tract Infection in Hospitalized Older Adults: a Prospective Study. Journal of general internal medicine. 2022 Academic Article GET IT
Times cited: 2
Pharmacokinetics and Pharmacodynamics of Ibrexafungerp. Drugs in R&D. 2021 Review GET IT
Times cited: 8
Ethical challenges of prospective clinical trials during the COVID-19 pandemic. Expert review of anti-infective therapy. 2021 Academic Article GET IT
The Great Gatsby and the challenge of unreliable narrators. Lancet (London, England). 2021 Academic Article GET IT
Clinical Pharmacokinetics and Pharmacodynamics of Lefamulin. Clinical pharmacokinetics. 2021 Review GET IT
Times cited: 1
At-home coronavirus testing: the next game-changer?. Expert review of molecular diagnostics. 2021 Editorial Article GET IT
Times cited: 7
Efficacy of Amphotericin B in Corneal Preservation Media After Extended Frozen Storage. Cornea. 2020 Academic Article GET IT
Times cited: 4
Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine. Expert review of anti-infective therapy. 2020 Review GET IT
Times cited: 6
Clinical Pharmacokinetics and Pharmacodynamics of Imipenem-Cilastatin/Relebactam Combination Therapy. Clinical pharmacokinetics. 2020 Review GET IT
Times cited: 10
Cefiderocol to treat complicated urinary tract infection. Drugs of today (Barcelona, Spain : 1998). 2020 Review GET IT
Times cited: 5
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial. Infectious diseases and therapy. 2019 Academic Article GET IT
Times cited: 20
Procalcitonin utilization in the real world: An observational study of antibiotic prescribing practices. Journal of evaluation in clinical practice. 2019 Academic Article GET IT
Clinical Pharmacokinetics and Pharmacodynamics of Eravacycline. Clinical pharmacokinetics. 2019 Review GET IT
Times cited: 11
Clinical Progress Note: Procalcitonin in the Diagnosis and Management of Community-Acquired Pneumonia in Hospitalized Adults. Journal of hospital medicine. 2019 Academic Article GET IT
Times cited: 1
Frequency of Ethical Issues on a Hospitalist Teaching Service at an Urban, Tertiary Care Center. Journal of hospital medicine. 2019 Academic Article GET IT
Times cited: 4
The expanding use of matrix-assisted laser desorption/ionization-time of flight mass spectroscopy in the diagnosis of patients with mycotic diseases. Expert review of molecular diagnostics. 2019 Review GET IT
Times cited: 18
Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole. Clinical pharmacokinetics. 2018 Review GET IT
Times cited: 26
Teixobactin: a novel anti-infective agent. Expert review of anti-infective therapy. 2018 Editorial Article GET IT
Times cited: 15
The surviving sepsis controversy: a call to action for hospital medicine. Expert review of anti-infective therapy. 2018 Academic Article GET IT
Candidemia in the cancer patient: diagnosis, treatment, and future directions. Expert review of anti-infective therapy. 2018 Review GET IT
Times cited: 14
Plazomicin for the treatment of patients with complicated urinary tract infection. Drugs of today (Barcelona, Spain : 1998). 2018 Review GET IT
Times cited: 3
Galactomannan antigenemia as a biomarker for therapeutic response of invasive aspergillosis: implications for clinical trial design and patient care. Expert review of molecular diagnostics. 2018 Review GET IT
Times cited: 5
Recent Advances in the Treatment of Scedosporiosis and Fusariosis. Journal of fungi (Basel, Switzerland). 2018 Review GET IT
Times cited: 8
The rise of hospitalists: an opportunity for infectious diseases investigators. Expert review of anti-infective therapy. 2018 Academic Article GET IT
Times cited: 4
Amino Acid Metabolism and Transport Mechanisms as Potential Antifungal Targets. International journal of molecular sciences. 2018 Review GET IT
Times cited: 18
Cefiderocol: a novel siderophore cephalosporin. Expert opinion on investigational drugs. 2018 Review GET IT
Times cited: 45
The prognostic value of mid-regional pro-adrenomedullin in the evaluation of acute dyspnea. Expert review of molecular diagnostics. 2018 Review GET IT
Off the Charts: Medical documentation and selective redaction in the age of transparency. Perspectives in biology and medicine. 2018 Academic Article GET IT
Times cited: 4
Novel applications for serum procalcitonin testing in clinical practice. Expert review of molecular diagnostics. 2017 Review GET IT
Times cited: 36
Containment strategies to address the expanding threat of multidrug-resistant Candida auris. Expert review of anti-infective therapy. 2017 Review GET IT
Times cited: 4
Advances in the management of fungal infections. Clinical advances in hematology & oncology : H&O. 2017 Article GET IT
In vitro combination therapy with isavuconazole against Candida spp. Medical mycology. 2017 Academic Article GET IT
Times cited: 17
Meropenem/vaborbactam fixed combination for the treatment of patients with complicated urinary tract infections. Drugs of today (Barcelona, Spain : 1998). 2017 Review GET IT
Times cited: 4
Fungal Infections of the Central Nervous System in Children. Journal of the Pediatric Infectious Diseases Society. 2017 Review GET IT
Times cited: 22
Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis. Antimicrobial agents and chemotherapy. 2017 Academic Article GET IT
Times cited: 13
Future Research Priorities in Fungal Resistance. The Journal of infectious diseases. 2017 Academic Article GET IT
Times cited: 26
Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi. The Journal of infectious diseases. 2017 Review GET IT
Times cited: 112
Drugs currently under investigation for the treatment of invasive candidiasis. Expert opinion on investigational drugs. 2017 Review GET IT
Times cited: 20
Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis. Expert review of respiratory medicine. 2017 Review GET IT
Times cited: 6
Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses. International journal of molecular sciences. 2017 Review GET IT
Times cited: 17
Drug development challenges and strategies to address emerging and resistant fungal pathogens. Expert review of anti-infective therapy. 2017 Review GET IT
Times cited: 35
Combination therapy for the treatment of pulmonary mold infections. Expert review of respiratory medicine. 2017 Review GET IT
Times cited: 8
The Care of the Ultra-Orthodox Jewish Patient. 2017 GET IT
Times cited: 24
Nucleic acid amplification methodologies for the detection of pulmonary mold infections. Expert review of molecular diagnostics. 2017 Review GET IT
Times cited: 10
Prophylactic Measures During Induction for Acute Myeloid Leukemia. Current oncology reports. 2017 Review GET IT
Times cited: 13
Diagnosis, classification, and therapeutic interventions for sinopulmonary Aspergillosis. Expert review of respiratory medicine. 2017 Review GET IT
Times cited: 7
The Rise of Hospitalists: An Opportunity for Clinical Ethics. The Journal of clinical ethics. 2017 Academic Article GET IT
Times cited: 6
Molecular diagnosis of invasive mycoses of the central nervous system. Expert review of molecular diagnostics. 2016 Review GET IT
Times cited: 12
PCR methodology and applications for the detection of human fungal pathogens. Expert review of molecular diagnostics. 2016 Review GET IT
Times cited: 32
What Hospitalists Should Know About Intersex Adults. Perspectives in biology and medicine. 2016 Academic Article GET IT
Times cited: 3
Clinical features and biomarkers of concussion and mild traumatic brain injury in pediatric patients. Annals of the New York Academy of Sciences. 2015 Review GET IT
Times cited: 22
Emerging drugs and vaccines for candidemia. Mycoses. 2014 Review GET IT
Times cited: 29
Use of a commercial HIV co-receptor tropism assay in clinical practice. AIDS patient care and STDs. 2014 Letter GET IT
Times cited: 1
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms. The Journal of antimicrobial chemotherapy. 2014 Academic Article GET IT
Times cited: 88
In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds. Antimicrobial agents and chemotherapy. 2014 Academic Article GET IT
Times cited: 39
Mold infections of the central nervous system. The New England journal of medicine. 2014 Review GET IT
Times cited: 119

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Tele-ACES (Appropriate Care and Escalation Strategies): A Simulation-Based Curriculum and Assessment to Teach Patient Safety in Telemedicine awarded by Association of American Medical Colleges Co-Investigator 2023 - 2025

Dalbavancin as an Option for Treatment of S. aureus Bacteremia (DOTS): A Phase 2b, Multicenter, Randomized, Open-Label, Assessor-Blinded Superiority Study to Compare the Efficacy and Safety of Dalbavancin to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients with Complicated S. aureus Bacteremia awarded by National Institute of Allergy & Infectious Diseases Principal Investigator Subaward 2020 - 2026
A Mechanistic substudy of the effects of crizanlizumab and dapagliflozin on thrombosis and inflammation in COVID-19 awarded by Commonwealth Fund Principal Investigator Subaward 2022 - 2023
ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications awarded by National Institute of Allergy & Infectious Diseases Principal Investigator Subaward 2021 - 2023

more ...

less ...

Background

education and training

M.D., Harvard Medical School 2008
B.S., Yale University 2002

Contact

full name

Matthew William McCarthy

primary email

mwm9004@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Matthew William McCarthy Associate Professor of Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage